Literature DB >> 31777646

Intraoperative methadone for postoperative pain management - systematic review protocol.

Zhaosheng Jin1, Erica J Lin1,2, Yaohua He3, Jun Lin1.   

Abstract

Methadone is a long acting opioid initially used to treat opioid withdrawal symptoms. It has been suggested that methadone, when given as a single bolus while under anesthesia, provides good postoperative analgesia and is associated with minimal risk of opioid adverse events. Several small studies have investigated the use of methadone for postoperative analgesia with some promising results. Here we describe our protocol for a meta-analysis to investigate the postoperative analgesic effect of methadone. IJPPP
Copyright © 2019.

Entities:  

Keywords:  Methadone; opioids; postoperative pain

Year:  2019        PMID: 31777646      PMCID: PMC6872483     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  13 in total

Review 1.  Safety and efficacy of patient-controlled analgesia.

Authors:  P E Macintyre
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

Review 2.  The clinical role of NMDA receptor antagonists for the treatment of postoperative pain.

Authors:  Marc F De Kock; Patricia M Lavand'homme
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2007-03

3.  Intraoperative methadone: rediscovery, reappraisal, and reinvigoration?

Authors:  Evan D Kharasch
Journal:  Anesth Analg       Date:  2011-01       Impact factor: 5.108

Review 4.  Methadone: a review of its pharmacokinetic/pharmacodynamic properties.

Authors:  M J Garrido; I F Trocóniz
Journal:  J Pharmacol Toxicol Methods       Date:  1999-10       Impact factor: 1.950

5.  Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.

Authors: 
Journal:  Anesthesiology       Date:  2012-02       Impact factor: 7.892

6.  Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain.

Authors:  Maria Luisa Sotgiu; Maurizio Valente; Riccardo Storchi; Giancarlo Caramenti; Gabriele E M Biella
Journal:  Pharmacol Res       Date:  2009-04-11       Impact factor: 7.658

7.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.

Authors:  Ingolf Meineke; Stefan Freudenthaler; Ute Hofmann; Elke Schaeffeler; Gerd Mikus; Matthias Schwab; Hilmar W Prange; Christoph H Gleiter; J Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

8.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 10.  Poorly controlled postoperative pain: prevalence, consequences, and prevention.

Authors:  Tong J Gan
Journal:  J Pain Res       Date:  2017-09-25       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.